Vaccine myocarditis risk reaches 1 in 10,000 for adolescent boys But while the rate of Pfizer-related myocarditis continues to increase in males aged 12–17, research cited by the TGA indicates the risk is still dwarfed by the threat COVID-19 poses to this cohort.
How vaccine companies are responding to Omicron Scientists are scrambling to test and potentially update their vaccine candidates against the latest COVID variant of concern.
COVID vaccine indemnity threshold reduced The change will enable more people to access compensation for vaccine injury, according to the Federal Health Minister.
Processing for COVID-19 vaccine compensation scheme to begin next month Around 10,000 potential claims related to adverse reactions have been registered since September.
GPs to receive access to Moderna, DoH confirms The RACGP has welcomed the news, which will add another string to GPs’ bow in their efforts to vaccinate Australians against COVID.
Sixty new cases of myocarditis in TGA’s latest safety report The rare side effect has been more common in adolescent boys after receiving the second dose of mRNA vaccine.
How to access Medicare support for third COVID vaccine doses GPs can conduct suitability assessments and administer third doses with the same item numbers used for second doses.
COVID-19 vaccination reduces household transmission up to 97% The new research findings also appear to be reflected by the recent downward trend in Australian locally acquired cases, a former World Health Organization epidemiologist says.
Immunocompromised require third COVID vaccine dose: ATAGI The additional dose is considered part of the primary regimen and is intended to generate an immune response equivalent to the general population.
TGA monitoring overseas Moderna recommendations Several countries have limited the use of the mRNA vaccine in younger people, but there is no sign Australia will institute a similar pause.